{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T04:03:03Z","timestamp":1769918583811,"version":"3.49.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T00:00:00Z","timestamp":1558483200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T00:00:00Z","timestamp":1558483200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["T32HL069771"],"award-info":[{"award-number":["T32HL069771"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01 DK106201"],"award-info":[{"award-number":["R01 DK106201"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s00125-019-4901-6","type":"journal-article","created":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T16:51:15Z","timestamp":1558543875000},"page":"1366-1374","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Fasting glucose variability in young adulthood and incident diabetes, cardiovascular disease and all-cause mortality"],"prefix":"10.1007","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3694-6060","authenticated-orcid":false,"given":"Michael P.","family":"Bancks","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"April P.","family":"Carson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cora E.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica P.","family":"Gunderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jared P.","family":"Reis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela J.","family":"Schreiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichiro","family":"Yano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mercedes R.","family":"Carnethon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,5,22]]},"reference":[{"key":"4901_CR1","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.2337\/dc17-S001","volume":"40","author":"American Diabetes Association","year":"2017","unstructured":"American Diabetes Association (2017) Standards of medical care in diabetes \u2014 2017. Diabetes Care 40:S1\u2013S135","journal-title":"Diabetes Care"},{"issue":"12","key":"4901_CR2","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.2337\/dc17-1600","volume":"40","author":"T Danne","year":"2017","unstructured":"Danne T, Nimri R, Battelino T et al (2017) International consensus on use of continuous glucose monitoring. Diabetes Care 40(12):1631\u20131640. \n                    https:\/\/doi.org\/10.2337\/dc17-1600","journal-title":"Diabetes Care"},{"issue":"8","key":"4901_CR3","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.2337\/dc14-0199","volume":"37","author":"Y Hirakawa","year":"2014","unstructured":"Hirakawa Y, Arima H, Zoungas S et al (2014) Impact of visit-to-visit glycemic variability on the risks of macrovascular and microvascular events and all-cause mortality in type 2 diabetes: the ADVANCE trial. Diabetes Care 37(8):2359\u20132365. \n                    https:\/\/doi.org\/10.2337\/dc14-0199","journal-title":"Diabetes Care"},{"issue":"1","key":"4901_CR4","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s00125-017-4423-z","volume":"61","author":"B Zinman","year":"2018","unstructured":"Zinman B, Marso SP, Poulter NR et al (2018) Day-to-day fasting glycaemic variability in DEVOTE: associations with severe hypoglycaemia and cardiovascular outcomes (DEVOTE 2). Diabetologia 61(1):48\u201357. \n                    https:\/\/doi.org\/10.1007\/s00125-017-4423-z","journal-title":"Diabetologia"},{"issue":"1","key":"4901_CR5","doi-asserted-by":"publisher","first-page":"39633","DOI":"10.1038\/srep39633","volume":"6","author":"D Xu","year":"2016","unstructured":"Xu D, Fang H, Xu W, Yan Y, Liu Y, Yao B (2016) Fasting plasma glucose variability and all-cause mortality among type 2 diabetes patients: a dynamic cohort study in Shanghai, China. Sci Rep 6(1):39633. \n                    https:\/\/doi.org\/10.1038\/srep39633","journal-title":"Sci Rep"},{"issue":"1","key":"4901_CR6","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12916-014-0165-7","volume":"12","author":"CC Lin","year":"2014","unstructured":"Lin CC, Yang CP, Li CI et al (2014) Visit-to-visit variability of fasting plasma glucose as predictor of ischemic stroke: competing risk analysis in a national cohort of Taiwan Diabetes Study. BMC Med 12(1):165. \n                    https:\/\/doi.org\/10.1186\/s12916-014-0165-7","journal-title":"BMC Med"},{"issue":"10","key":"4901_CR7","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.2337\/dc18-0548","volume":"41","author":"JJ Zhou","year":"2018","unstructured":"Zhou JJ, Schwenke DC, Bahn G, Reaven P (2018) Glycemic variation and cardiovascular risk in the Veteran\u2019s Affairs Diabetes Trial. Diabetes Care 41(10):2187\u20132194. \n                    https:\/\/doi.org\/10.2337\/dc18-0548","journal-title":"Diabetes Care"},{"key":"4901_CR8","doi-asserted-by":"publisher","unstructured":"Wang A, Liu X, Xu J et al (2017) Visit-to-visit variability of fasting plasma glucose and the risk of cardiovascular disease and all-cause mortality in the general population. J Am Heart Assoc 6(12):e006757. \n                    https:\/\/doi.org\/10.1161\/JAHA.117.006757","DOI":"10.1161\/JAHA.117.006757"},{"issue":"8","key":"4901_CR9","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1111\/dom.13306","volume":"20","author":"E Orsi","year":"2018","unstructured":"Orsi E, Solini A, Bonora E et al (2018) Haemoglobin A1c variability is a strong, independent predictor of all-cause mortality in patients with type 2 diabetes. Diabetes Obes Metab 20(8):1885\u20131893. \n                    https:\/\/doi.org\/10.1111\/dom.13306","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"4901_CR10","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12933-018-0677-0","volume":"17","author":"CRL Cardoso","year":"2018","unstructured":"Cardoso CRL, Leite NC, Moram CBM, Salles GF (2018) Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study. Cardiovasc Diabetol 17(1):33. \n                    https:\/\/doi.org\/10.1186\/s12933-018-0677-0","journal-title":"Cardiovasc Diabetol"},{"issue":"7","key":"4901_CR11","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1210\/jc.2017-00450","volume":"102","author":"A Akirov","year":"2017","unstructured":"Akirov A, Diker-Cohen T, Masri-Iraqi H, Shimon I (2017) High glucose variability increases mortality risk in hospitalized patients. J Clin Endocrinol Metab 102(7):2230\u20132241. \n                    https:\/\/doi.org\/10.1210\/jc.2017-00450","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"4901_CR12","doi-asserted-by":"publisher","first-page":"4091","DOI":"10.2337\/dc12-2430","volume":"36","author":"CE Mendez","year":"2013","unstructured":"Mendez CE, Mok KT, Ata A, Tanenberg RJ, Calles-Escandon J, Umpierrez GE (2013) Increased glycemic variability is independently associated with length of stay and mortality in noncritically ill hospitalized patients. Diabetes Care 36(12):4091\u20134097. \n                    https:\/\/doi.org\/10.2337\/dc12-2430","journal-title":"Diabetes Care"},{"issue":"4","key":"4901_CR13","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s00134-010-2129-5","volume":"37","author":"S Eslami","year":"2011","unstructured":"Eslami S, Taherzadeh Z, Schultz MJ, Abu-Hanna A (2011) Glucose variability measures and their effect on mortality: a systematic review. Intensive Care Med 37(4):583\u2013593. \n                    https:\/\/doi.org\/10.1007\/s00134-010-2129-5","journal-title":"Intensive Care Med"},{"issue":"44","key":"4901_CR14","doi-asserted-by":"publisher","first-page":"e1804","DOI":"10.1097\/MD.0000000000001804","volume":"94","author":"YF Yang","year":"2015","unstructured":"Yang YF, Li TC, Li CI et al (2015) Visit-to-visit glucose variability predicts the development of end-stage renal disease in type 2 diabetes: 10-year follow-up of Taiwan Diabetes Study. Medicine 94(44):e1804. \n                    https:\/\/doi.org\/10.1097\/MD.0000000000001804","journal-title":"Medicine"},{"issue":"11","key":"4901_CR15","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/0895-4356(88)90080-7","volume":"41","author":"GD Friedman","year":"1988","unstructured":"Friedman GD, Cutter GR, Donahue RP et al (1988) CARDIA: study design, recruitment, and some characteristics of the examined subjects. J Clin Epidemiol 41(11):1105\u20131116. \n                    https:\/\/doi.org\/10.1016\/0895-4356(88)90080-7","journal-title":"J Clin Epidemiol"},{"issue":"11","key":"4901_CR16","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1097\/00008483-198911000-00003","volume":"9","author":"DJ Jacobs","year":"1989","unstructured":"Jacobs DJ, Hahn L, Haskell W, Pirie P, Sidney S (1989) Validity and reliability of a short physical activity history: CARDIA and the Minnesota Heart Health Program. J Cardpulm Rehabil 9(11):448\u2013459. \n                    https:\/\/doi.org\/10.1097\/00008483-198911000-00003","journal-title":"J Cardpulm Rehabil"},{"key":"4901_CR17","first-page":"127","volume":"41","author":"American College of Sports Medicine","year":"1993","unstructured":"American College of Sports Medicine (1993) The recommended quantity and quality of exercise for developing and maintaining cardiorespiratory and muscular fitness in healthy adults. Position stand of the American College of Sports Medicine. Schweiz Z Sportmed 41:127\u2013137","journal-title":"Schweiz Z Sportmed"},{"issue":"2","key":"4901_CR18","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1097\/HJH.0b013e32832258c9","volume":"27","author":"A Hozawa","year":"2009","unstructured":"Hozawa A, Jacobs DR Jr, Steffes MW, Gross MD, Steffen LM, Lee DH (2009) Circulating carotenoid concentrations and incident hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) study. J Hypertens 27(2):237\u2013242. \n                    https:\/\/doi.org\/10.1097\/HJH.0b013e32832258c9","journal-title":"J Hypertens"},{"issue":"3","key":"4901_CR19","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/1047-2797(96)00005-1","volume":"6","author":"DE Bild","year":"1996","unstructured":"Bild DE, Jacobs DR, Liu K et al (1996) Seven-year trends in plasma low-density-lipoprotein-cholesterol in young adults: the CARDIA Study. Ann Epidemiol 6(3):235\u2013245. \n                    https:\/\/doi.org\/10.1016\/1047-2797(96)00005-1","journal-title":"Ann Epidemiol"},{"key":"4901_CR20","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/0076-6879(86)29064-3","volume":"129","author":"GR Warnick","year":"1986","unstructured":"Warnick GR (1986) Enzymatic methods for quantification of lipoprotein lipids. Methods Enzymol 129:101\u2013123","journal-title":"Methods Enzymol"},{"issue":"6","key":"4901_CR21","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","volume":"18","author":"WT Friedewald","year":"1972","unstructured":"Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18(6):499\u2013502","journal-title":"Clin Chem"},{"issue":"7","key":"4901_CR22","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.2337\/dc09-0259","volume":"32","author":"K Park","year":"2009","unstructured":"Park K, Gross M, Lee DH et al (2009) Oxidative stress and insulin resistance: the Coronary Artery Risk Development in Young Adults Study. Diabetes Care 32(7):1302\u20131307. \n                    https:\/\/doi.org\/10.2337\/dc09-0259","journal-title":"Diabetes Care"},{"issue":"24","key":"4901_CR23","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1001\/jama.2017.19546","volume":"318","author":"MP Bancks","year":"2017","unstructured":"Bancks MP, Kershaw K, Carson AP, Gordon-Larsen P, Schreiner PJ, Carnethon MR (2017) Association of modifiable risk factors in young adulthood with racial disparity in incident type 2 diabetes during middle adulthood. JAMA 318(24):2457\u20132465. \n                    https:\/\/doi.org\/10.1001\/jama.2017.19546","journal-title":"JAMA"},{"issue":"11","key":"4901_CR24","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.2337\/dc08-0864","volume":"31","author":"ES Kilpatrick","year":"2008","unstructured":"Kilpatrick ES, Rigby AS, Atkin SL (2008) A1C variability and the risk of microvascular complications in type 1 diabetes: data from the Diabetes Control and Complications Trial. Diabetes Care 31(11):2198\u20132202. \n                    https:\/\/doi.org\/10.2337\/dc08-0864","journal-title":"Diabetes Care"},{"issue":"5","key":"4901_CR25","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1161\/HYPERTENSIONAHA.114.03978","volume":"64","author":"Y Yano","year":"2014","unstructured":"Yano Y, Ning H, Allen N et al (2014) Long-term blood pressure variability throughout young adulthood and cognitive function in midlife: the Coronary Artery Risk Development in Young Adults (CARDIA) study. Hypertension 64(5):983\u2013988. \n                    https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.114.03978","journal-title":"Hypertension"},{"issue":"9","key":"4901_CR26","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.2337\/dc16-2238","volume":"40","author":"T-C Li","year":"2017","unstructured":"Li T-C, Yang C-P, Tseng S-T et al (2017) Visit-to-visit variations in fasting plasma glucose and HbA1c associated with an increased risk of Alzheimer disease: Taiwan Diabetes Study. Diabetes Care 40(9):1210\u20131217. \n                    https:\/\/doi.org\/10.2337\/dc16-2238","journal-title":"Diabetes Care"},{"issue":"7","key":"4901_CR27","doi-asserted-by":"publisher","first-page":"e0132118","DOI":"10.1371\/journal.pone.0132118","volume":"10","author":"C Kim","year":"2015","unstructured":"Kim C, Sohn JH, Jang MU et al (2015) Association between visit-to-visit glucose variability and cognitive function in aged type 2 diabetic patients: a cross-sectional study. PLoS One 10(7):e0132118. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0132118","journal-title":"PLoS One"},{"issue":"3","key":"4901_CR28","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1177\/0962280206074463","volume":"16","author":"S van Buuren","year":"2007","unstructured":"van Buuren S (2007) Multiple imputation of discrete and continuous data by fully conditional specification. Stat Methods Med Res 16(3):219\u2013242. \n                    https:\/\/doi.org\/10.1177\/0962280206074463","journal-title":"Stat Methods Med Res"},{"key":"4901_CR29","unstructured":"Yuan YC (2000) Multiple Imputation for missing data: concepts and new development (version 9.0). In: Proceedings of the Twenty-Fifth Annual SAS Users Group International Conference. SAS Institute, Cary, NC, pp 1\u201311"},{"issue":"6","key":"4901_CR30","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1161\/CIRCULATIONAHA.115.017719","volume":"133","author":"PC Austin","year":"2016","unstructured":"Austin PC, Lee DS, Fine JP (2016) Introduction to the analysis of survival data in the presence of competing risks. Circulation 133(6):601\u2013609. \n                    https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.017719","journal-title":"Circulation"},{"issue":"12","key":"4901_CR31","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.2337\/dc18-0802","volume":"41","author":"JA Kim","year":"2018","unstructured":"Kim JA, Lee JS, Chung HS et al (2018) Impact of visit-to-visit fasting plasma glucose variability on the development of type 2 diabetes: a nationwide population-based cohort study. Diabetes Care 41(12):2610\u20132616. \n                    https:\/\/doi.org\/10.2337\/dc18-0802","journal-title":"Diabetes Care"},{"issue":"1","key":"4901_CR32","doi-asserted-by":"publisher","first-page":"134","DOI":"10.2337\/dc18-1396","volume":"42","author":"J Ghouse","year":"2018","unstructured":"Ghouse J, Skov MW, Kanters JK et al (2018) Visit-to-visit variability of hemoglobin A1c in people without diabetes and risk of major adverse cardiovascular events and all-cause mortality. Diabetes Care 42(1):134\u2013141. \n                    https:\/\/doi.org\/10.2337\/dc18-1396","journal-title":"Diabetes Care"},{"issue":"14","key":"4901_CR33","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1001\/jama.295.14.1681","volume":"295","author":"L Monnier","year":"2006","unstructured":"Monnier L, Mas E, Ginet C et al (2006) Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 295(14):1681\u20131687. \n                    https:\/\/doi.org\/10.1001\/jama.295.14.1681","journal-title":"JAMA"},{"issue":"4","key":"4901_CR34","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1007\/s11892-013-0383-y","volume":"13","author":"ST Keating","year":"2013","unstructured":"Keating ST, El-Osta A (2013) Glycemic memories and the epigenetic component of diabetic nephropathy. Curr Diab Rep 13(4):574\u2013581. \n                    https:\/\/doi.org\/10.1007\/s11892-013-0383-y","journal-title":"Curr Diab Rep"},{"key":"4901_CR35","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1056\/NEJMoa012512","volume":"346","author":"Diabetes Prevention Program Research Group","year":"2002","unstructured":"Diabetes Prevention Program Research Group (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393\u2013403","journal-title":"N Engl J Med"},{"issue":"9702","key":"4901_CR36","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1016\/S0140-6736(09)61457-4","volume":"374","author":"WC Knowler","year":"2009","unstructured":"Knowler WC, Fowler SE, Hamman RF et al (2009) 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet 374(9702):1677\u20131686. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(09)61457-4","journal-title":"Lancet"},{"issue":"3","key":"4901_CR37","doi-asserted-by":"publisher","first-page":"486","DOI":"10.2337\/dc18-1430","volume":"42","author":"J Echouffo-Tcheugui","year":"2019","unstructured":"Echouffo-Tcheugui J, Zhao S, Brock G, Matsouaka R, Kline D, Joseph J (2019) Visit-to-visit glycemic variability and risks of cardiovascular events and all-cause mortality: the ALLHAT study. Diabetes Care 42(3):486\u2013493. \n                    https:\/\/doi.org\/10.2337\/dc18-1430","journal-title":"Diabetes Care"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-019-4901-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-019-4901-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-019-4901-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T00:03:10Z","timestamp":1590105790000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-019-4901-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,22]]},"references-count":37,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["4901"],"URL":"https:\/\/doi.org\/10.1007\/s00125-019-4901-6","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,22]]},"assertion":[{"value":"3 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"EPG receives funding unrelated to the current study from Janssen Pharmaceuticals, Inc. (June 2017). APC receives research funding unrelated to the current study from Amgen, Inc. The remaining authors declare that there is no duality of interest associated with this manuscript. The views expressed in this manuscript are those of the authors and do not necessarily represent the views of the NHLBI, the National Institutes of Health or the US Department of Health and Human Services.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Duality of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}